| 51 | 301 |
•
Routine HIV testing of all patients aged 13 – 65 years
|
| 51 | 354 |
•
Repeat HIV testing for high-risk populations
|
| 51 | 302 |
•
Routine, early HIV testing for all pregnant women
|
| 51 | 303 |
•
Recruitment methods for clinical HIV testing
|
| 51 | 304 |
•
Integration of clinical HIV testing with screening for sexually transmitted diseases (STDs), hepatitis B virus (HBV), hepatitis C virus (HCV), and tuberculosis (TB)
|
| 51 | 305 |
•
Integration of HIV testing with other programs and services in clinical settings
|
| 51 | 306 |
•
Assessing and improving performance of HIV testing programs based in clinical settings
|
| 51 | 307 |
•
HIV testing technologies for clinical settings
|
| 51 | 308 |
•
Leveraging existing third-party billing systems for reimbursement of eligible costs associated with HIV testing in clinical settings
|
| 51 | 309 |
•
Referrals to HIV medical care for persons with positive HIV test results
|
| 51 | 310 |
•
Referrals to PrEP (pre-exposure prophylaxis) services
|
| 51 | 311 |
•
Referrals to STD, viral hepatitis, and/or TB screening
|
| 51 | 355 |
•
Referrals to other prevention and essential support services, as needed
|
| 51 | 312 |
•
Referrals to post-exposure prophylaxis (PEP) services
|
| 51 | 361 |
•
HIV self-testing
|
| 51 | 362 |
•
Other self-testing (HCV, STIs, etc.)
|